Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Michael Myers, M.D., CEO of the Quoin pharmaceutical company describes Netherton Syndrome as a devastating skin disorder that at times may be fatal. In a recent article published in BioSpace,…
Continue Reading
Netherton Syndrome: The Second Clinical Study Has Been FDA Approved to Begin Testing For This Rare Skin Disease
source: pixabay.com
Cognitive deficits have been recognized as symptoms of advanced liver disease for many years. As reported in Bioengineer, the American Journal of Pathology recently published a study providing insights…
Continue Reading
Obeticholic Acid Resolves Cognitive Deficits from Primary Biliary Cholangitis
source: pixabay.com
The 64th ASH Annual Meeting held on December 10, 2022, focused on various approaches for hematologic diseases with the goal of improving quality care and outcomes. Dr. Stephanie Lee, of…
Continue Reading
Promising Research Results from the 64th ASH Annual Meeting
Jenny Decker of Fenton, MO. interviewed with KMOV4 explaining that she was unable to walk when she was three years old due to a rare disease called Charcot-Marie-Tooth disease. Doctors…
Continue Reading
Charcot-Marie-Tooth Patient Overcomes Her Disability by Sailing Solo Around the Globe
Sangamo Therapeutics, with its primary focus on genomic medicine, recently issued a news release announcing data from its phase 1/2 STARR trial. The data evaluated isaralgagene civaparvovec, or (ST-920) as…
Continue Reading
Fabry Disease: Sangamo Therapeutics Announces Updated Data from its Clinical Trial
source: pixabay.com
Rare disease stakeholders are called on to participate in the first Rare Disease Therapeutic Alliance of 2023 featuring an agenda presented by Rare Advocacy Movement experts. The agenda will…
Continue Reading
Calling all Stakeholders to Attend the Rare Disease Therapeutic Alliance of 2023
source: pixabay.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: There is a Growing Awareness of the Need For Compassion in Healthcare
source: unsplash.com
423 words 10% matched vs 524 words 5% matched The Rare Diseases International Organization reports that the groundbreaking UN Resolution on Persons Living With a Rare Disease (PLWRD), effective…
Continue Reading
2021 UN Resolution to Recognize Persons Living with a Rare Disease to be Discussed in 2023 Session
source: pixabay.com
One year ago, in December 2021, clinical studies of lovo-cel for patients who were eighteen or younger were put on partial hold by the FDA. At the time, bluebird…
Continue Reading
Sickle Cell Disease: FDA Lifts Partial hold on bluebird’s Trial for Patients Under 18
Continued From Part One Multiple myeloma is caused by the buildup of abnormal white blood cells that form tumors found primarily in bones. Available treatments work for short periods…
Continue Reading
New Immunotherapy Proves Successful in 73 Percent of Multiple Myeloma Patients (Part 2)
source: shutterstock.com
Globe Newswire recently published an article announcing positive results from Amolyt Pharma’s Phase IIa proof of concept clinical trial of AZP-3601. Amolyt Pharma, Cambridge, Massachusetts, and Lyon, France, is a…
Continue Reading
Hypoparathyroidism: Positive Results from Phase 2a Trial
Part 1 Newswise recently published exciting news of a therapy that causes the immune system to destroy cancer cells in the bone marrow. Researchers at Icahn School’s Tisch Cancer Center…
Continue Reading
New Immunotherapy Proves Successful in 73 Percent of Multiple Myeloma Patients, (Part 1)
source: pixabay.com
Waldenstrom macroglobulinemia (WM) is defined as a B-cell lymphoplasmacytic lymphoma. Data from patients in Latin America on WM are scarce. Researchers are hoping to fill the void by analyzing…
Continue Reading
This May Be the First Published Report on Waldenstrom Macroglobulinemia in Latin America
source: pixabay.com
The latest statistics on heart disease and its effect on Black communities are startling. According to an article in the Dallas Examiner, Black people are fifty to seventy percent more…
Continue Reading
Transthyretin Amyloid Cardiomyopathy: An Underrecognized Disease in the Black Community
source: pixabay.com
A team of researchers at Shanghai’s Fudan University, acting upon the knowledge that ketogenic diets can boost liver ketone production, have recently examined the possibility of preventing thrombocytopenia (low…
Continue Reading
The Ketogenic Diet May Have Benefits During Chemotherapy
source: pixabay.com
Do you wish to be heard? Recently PR Newswire announced that on the 28th of February 2023, NORD and the worldwide community of rare disorders will be raising awareness…
Continue Reading
National Organization of Rare Disorders: Raising Awareness of Rare Disease Day 2023
source: pixabay.com
Contrary to simply stopping tumor growth, the biomedical engineers at Duke University have successfully demonstrated a new treatment for pancreatic cancer in a mouse model that may make a…
Continue Reading
An Exciting New Procedure That Could Make an Impact on Pancreatic Cancer
source: pixabay.com
Med City News published an article by Bruce Feinberg, M.D. at Cardinal Heath, examining CAR-T treatments and the impact they have had in medicine during the past five years. CAR-T's…
Continue Reading
CAR-T Cell Therapy is Changing the Future of Medicine as We Know It
source: shutterstock.com
Editor's Note: Chronic conditions and rare diseases don't discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have…
Continue Reading
Bridging the Diversity Gap in Healthcare
source: pixabay.com
In 2021, Alyssa, who is now thirteen years old, and her family were told that she had acute lymphoblastic leukemia. Alyssa did not respond to either the standard leukemia…
Continue Reading
Alyssa is the First Person to Receive a New Treatment for Acute Lymphoblastic Leukemia
According to a recent article featured in Biospace, researchers found substantial evidence of a biochemical correction after treating an eleven-year girl for Gaucher Disease. This is the first pediatric case…
Continue Reading
Promising Gene Therapy Seeking Approval to Treat Advanced Gaucher Disease
source: unsplash.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: How Can Technology Help Us Be Compassionate to Ourselves?
source: pixabay.com
Researchers at Brown University, in collaboration with an MIT research team, discovered a method of penetrating the blood-brain barrier (BBB) in mice and delivering medication to treat lethal tumors…
Continue Reading
Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors
Have you ever wondered how a rare disease can take control of a person’s life? The deteriorating health, being unable to receive an accurate diagnosis, and more importantly finding an…
Continue Reading
Improving a Rare Disease Patient’s Access to Specialty-Pharmaceuticals and Gene Therapies
Genetech recently announced the FDA’s approval of Tecentriq to treat alveolar soft part sarcoma (ASPS) pediatric and adult patients over the age of two. This first-ever treatment has been developed…
Continue Reading
The FDA Approves New Therapy for Rare Alveolar Soft Part Sarcoma (ASPS)